Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 351,230 |
|
|||||
| News | - | ||||||
| Day High | 16.41 | Low High |
|||||
| Day Low | 16.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Certara Inc | CERT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.15 | -0.91% | 16.30 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.21 | 16.00 | 16.41 | 16.30 | 16.45 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,182 | 351,230 | $ 16.23 | $ 5,700,710 | - | 11.81 - 24.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:41:50 | 2 | $ 15.84 | USD |
Certara Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.61B | 159.86M | - | 354.34M | -55.36M | -0.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Certara News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CERT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.97 | 16.97 | 15.78 | 16.27 | 517,543 | -0.67 | -3.95% |
| 1 Month | 17.70 | 19.1792 | 15.78 | 17.37 | 563,756 | -1.40 | -7.91% |
| 3 Months | 16.29 | 19.8702 | 15.78 | 17.64 | 537,918 | 0.01 | 0.06% |
| 6 Months | 13.24 | 19.8702 | 11.81 | 16.25 | 585,217 | 3.06 | 23.11% |
| 1 Year | 23.90 | 24.70 | 11.81 | 17.38 | 761,634 | -7.60 | -31.80% |
| 3 Years | 31.10 | 45.48 | 10.60 | 21.87 | 804,472 | -14.80 | -47.59% |
| 5 Years | 35.01 | 45.48 | 10.60 | 22.87 | 794,749 | -18.71 | -53.44% |
Certara Description
| Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States. |
